| Landals Speech Pathology, Pllc | |
|
163 Kennedy Rd, Paducah, KY 42001-4911 | |
| (931) 561-9802 | |
| Not Available |
| Full Name | Landals Speech Pathology, Pllc |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 163 Kennedy Rd, Paducah, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043095045 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Secondary |
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Landals Speech Pathology, Pllc 163 Kennedy Rd, Paducah, KY 42001-4911 Ph: () - | Landals Speech Pathology, Pllc 163 Kennedy Rd, Paducah, KY 42001-4911 Ph: (931) 561-9802 |
News Archive
West Nile Virus has made its first appearance of 2006 in Arizona, and state and local health officials are encouraging everyone to take precautions against the disease.
Vertex Pharmaceuticals Incorporated today announced new data from its Phase 3 studies of people with genotype 1 chronic hepatitis C who have not been treated previously. In these studies, the majority of people achieved superior sustained viral response (SVR or viral cure) rates with a telaprevir-based combination regimen, compared to current therapies, regardless of race/ethnicity or stage of liver fibrosis (factors known to limit response to current hepatitis C treatments).
The treatment of left main coronary artery disease by percutaneous coronary intervention is associated with a smaller risk of severe cardiovascular events than coronary artery bypass grafting in the weeks following surgery.
Vanda Pharmaceuticals Inc. announced today that the U.S. Patent and Trademark Office has issued a notice of allowance for its patent application of a microsphere, long-acting injectable formulation of its antipsychotic product, Fanapt™ (iloperidone). When issued, this U.S. patent will expire on October 30, 2022, and in addition, the U.S. Patent and Trademark Office has granted a patent term adjustment of 300 days, leading to an effective expiration date of August 26, 2023.
› Verified 8 days ago
Mrs. Amanda Ruth Lane, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 867 Mcguire Ave, Paducah, KY 42001 Phone: 270-442-6168 Fax: 270-443-6211 | |
Julie Blanchard, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 142 Stuart Nelson Park Road, Paducah, KY 42001 Phone: 270-442-9502 Fax: 270-442-1954 | |
Karley Byrd, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4747 Alben Barkley Dr, Paducah, KY 42001 Phone: 270-444-9661 | |
Caitlin Sullivan, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Kiana Ct, Paducah, KY 42001 Phone: 270-443-0681 | |
Erica Allen, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 513 N 34th St, Paducah, KY 42001 Phone: 270-564-4112 | |
Samantha Davis, M.S., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3227 Coleman Rd, Paducah, KY 42001 Phone: 270-442-6399 Fax: 270-442-6300 | |
Kelly Walker, MS., CCC-SLP, ATP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Bruce Ave, Paducah, KY 42001 Phone: 270-554-8948 |